US, French firms start drug trial in ... - Lung Conditions C...

Lung Conditions Community Forum

55,727 members66,370 posts

US, French firms start drug trial in severe COVID-19 cases

2greys profile image
0 Replies

French pharmaceutical giant Sanofi and American drugmaker Regeneron said Monday they have started clinical trials for a new drug in patients hospitalised with severe COVID-19 infections.

In a statement they said phase 2 and 3 trials were under way for Kevzara, an immunosuppressor.

Regeneron will trial in the United States, while Sanofi plans trials initially in Italy, particularly hard hit by the novel coronavirus pandemic.

business-standard.com/artic...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Table tennis consultant and Gp

not Covid and not an infection , not the Aspergillosis cough , he cannot take anti fungal drugs and...

Re earlier post on different forum.

above as moderate to severe calcification in the LAD vessel. You would have thought drug therapy...

Misdiagnosed with COPD

conversation with a lady who has emphysema. She said her GP surgery was doing testing as normal and...

Severe Scarring From Pneumonia

about my dad who is in his late 70s in ICU for severe pneumonia in the ICUsteps group, but here is...

Has anyone had a Spirometry test recently?

services are starting to do Spirometry tests again. I had a fairly mild case of Covid in April 2020